STOCK TITAN

Joseph Baroldi plans Common Stock sale via Stifel (IONS) — 4,096 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Joseph Baroldi filed a Form 144 to sell Common Stock. The filing lists 4,096 shares of Common Stock tied to Restricted Stock Units (grant date 01/15/2022) and identifies Stifel Nicolaus & Company Inc. as the broker for the proposed sale dated 03/03/2026. The filing also shows recent dispositions, including sales of 5,296 shares on 01/30/2026 and 6,999 shares on 01/16/2026, with associated aggregate amounts listed in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies the broker and SEC of a proposed resale of insider-held shares.

Form 144 identifies 4,096 shares linked to Restricted Stock Units (grant date 01/15/2022) and names Stifel Nicolaus & Company Inc. as the broker. The filing date shown is 03/03/2026.

Prior dispositions are listed as examples, including 5,296 shares (sold 01/30/2026) and 6,999 shares (sold 01/16/2026); the excerpt shows aggregate dollar entries alongside those dates. The filing documents the proposed method and recent activity; cash‑flow treatment and further sale mechanics are not detailed in the provided excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Joseph Baroldi's Form 144 for IONS report?

It reports a proposed sale of 4,096 shares of Common Stock tied to RSUs. The filing names Stifel Nicolaus & Company Inc. as broker and carries a filing date of 03/03/2026, with recent prior dispositions also listed.

How many shares are listed as securities to be sold in the filing?

The filing lists 4,096 shares as the securities to be sold. These are shown as Restricted Stock Units with a grant date of 01/15/2022 and are associated with equity compensation in the excerpt.

Does the Form 144 show any recent sales by Baroldi?

Yes; the filing shows recent dispositions of 5,296 and 6,999 shares. Those sales are dated 01/30/2026 and 01/16/2026, respectively, with aggregate dollar figures included in the excerpt.

Which broker is handling the proposed sale on the Form 144?

Stifel Nicolaus & Company Inc. is listed as the broker, with an address of 501 N Broadway, St. Louis, MO. The filing associates the broker with the proposed resale activity dated 03/03/2026.

Are the proceeds or detailed sale mechanics disclosed in the excerpt?

Specific proceeds use and detailed sale mechanics are not described in the excerpt. The filing displays aggregate dollar amounts beside recent dispositions but does not provide further allocation or method details in the provided content.
Ionis Pharmaceuticals

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Latest SEC Filings

IONS Stock Data

13.14B
160.40M
Biotechnology
Pharmaceutical Preparations
Link
United States
CARLSBAD